Jerzy Jankun
- Molecular Biology top 10%
- Cancer Research top 5%
- Pathology and Forensic Medicine top 2%
- Biochemistry top 1%
- Pharmacology top 5%
- Co-authors
- Ewa Skrzypczak‐JankunSteven H. SelmanRafal SwierczRick W. KeckN. Patrick McCabeMarzena Wyganowska‐ŚwiątkowskaAbdulrahman M. AlsenaidyOleg Y. Borbulevych
- Topics
- Protease and Inhibitor Mechanisms (31 papers)Blood Coagulation and Thrombosis Mechanisms (18 papers)Peptidase Inhibition and Analysis (9 papers)
- Journals
- NatureProceedings of the National Academy of SciencesSHILAP Revista de lepidopterología
- Partner nations
- United StatesPolandSaudi Arabia
In The Last Decade
Jerzy Jankun
96 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Molecular Biology 926
- Cancer Research 628
- Pathology and Forensic Medicine 573
- Biochemistry 401
- Pharmacology 333
Countries citing papers authored by Jerzy Jankun
This map shows the geographic impact of Jerzy Jankun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerzy Jankun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerzy Jankun more than expected).
Fields of papers citing papers by Jerzy Jankun
This network shows the impact of papers produced by Jerzy Jankun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerzy Jankun. The network helps show where Jerzy Jankun may publish in the future.
Co-authorship network of co-authors of Jerzy Jankun
This figure shows the co-authorship network connecting the top 25 collaborators of Jerzy Jankun. A scholar is included among the top collaborators of Jerzy Jankun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerzy Jankun. Jerzy Jankun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 21 | |
| 2 | 11 | |
| 3 | 7 | |
| 4 | 22 | |
| 5 | 2 | |
| 6 | 14 | |
| 7 | 11 | |
| 8 | 7 | |
| 9 | 25 | |
| 10 | Review paper Can drinking black tea fight diabetes: literature review and theoretical indication | 3 |
| 11 | Review paper The black tea bioactivity: an overview | 3 |
| 12 | 3 | |
| 13 | 29 | |
| 14 | 1 | |
| 15 | 17 | |
| 16 | 27 | |
| 17 | 2 | |
| 18 | A Kohonen Clustering based Approach to Segmentation of Prostate from TRUS Data using Gray-Level Co-occurrence Matrix. | 2 |
| 19 | 19 | |
| 20 | 80 |
About Jerzy Jankun
Jerzy Jankun is a scholar working on Cancer Research, Hematology and Applied Microbiology and Biotechnology, having authored 97 papers that have together received 3.0k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (31 papers), Blood Coagulation and Thrombosis Mechanisms (18 papers) and Peptidase Inhibition and Analysis (9 papers). The work is most often cited by research in Biochemistry (401 citations), Molecular Medicine (293 citations) and Applied Microbiology and Biotechnology (102 citations). Jerzy Jankun has collaborated with scholars based in United States, Poland and Saudi Arabia. Frequent co-authors include Ewa Skrzypczak‐Jankun, Steven H. Selman, Rafal Swiercz, Rick W. Keck, N. Patrick McCabe, Marzena Wyganowska‐Świątkowska, Abdulrahman M. Alsenaidy, Oleg Y. Borbulevych, Joanna Chorostowska‐Wynimko and Ansari M. Aleem. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.